Global Oncology Drugs Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Oncology Drugs market will register a 10.7%% CAGR in terms of revenue, the global market size will reach $ 236240 million by 2025, from $ 157520 million in 2019. In particular, this report presents the global revenue market share of key companies in Oncology Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Oncology Drugs, covering the supply chain analysis, impact assessment to the Oncology Drugs market size growth rate in several scenarios, and the measures to be undertaken by Oncology Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Eli Lilly
Celgene
Bristol-Myers Squibb
Johnson & Johnson
Novartis
Pfizer
Merck & Co.
Amgen
AstraZeneca
Bayer
Teva
Biogen Idec
AbbVie
Ipsen
Astellas
Eisai
Sanofi
Takeda
Otsuka
Gilead Sciences
Merck KGaA
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oncology Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Oncology Drugs market by identifying its various subsegments.
Focuses on the key global Oncology Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Drugs Market Size 2015-2025
2.1.2 Oncology Drugs Market Size CAGR by Region
2.2 Oncology Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Chemotherapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Drugs Market Size by Type
2.3.1 Global Oncology Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Oncology Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Oncology Drugs Market Size by Application
2.5.1 Global Oncology Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Oncology Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Oncology Drugs by Players
3.1 Global Oncology Drugs Market Size Market Share by Players
3.1.1 Global Oncology Drugs Market Size by Players (2018-2020)
3.1.2 Global Oncology Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Oncology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Drugs by Regions
4.1 Oncology Drugs Market Size by Regions
4.2 Americas Oncology Drugs Market Size Growth
4.3 APAC Oncology Drugs Market Size Growth
4.4 Europe Oncology Drugs Market Size Growth
4.5 Middle East & Africa Oncology Drugs Market Size Growth
5 Americas
5.1 Americas Oncology Drugs Market Size by Countries
5.2 Americas Oncology Drugs Market Size by Type
5.3 Americas Oncology Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oncology Drugs Market Size by Regions
6.2 APAC Oncology Drugs Market Size by Type
6.3 APAC Oncology Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Oncology Drugs by Countries
7.2 Europe Oncology Drugs Market Size by Type
7.3 Europe Oncology Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Oncology Drugs by Countries
8.2 Middle East & Africa Oncology Drugs Market Size by Type
8.3 Middle East & Africa Oncology Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Oncology Drugs Market Forecast
10.1 Global Oncology Drugs Market Size Forecast (2021-2025)
10.2 Global Oncology Drugs Forecast by Regions
10.2.1 Global Oncology Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Oncology Drugs Forecast by Type
10.8 Global Oncology Drugs Forecast by Application
11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Oncology Drugs Product Offered
11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 Eli Lilly
11.2.1 Company Details
11.2.2 Oncology Drugs Product Offered
11.2.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Eli Lilly News
11.3 Celgene
11.3.1 Company Details
11.3.2 Oncology Drugs Product Offered
11.3.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Celgene News
11.4 Bristol-Myers Squibb
11.4.1 Company Details
11.4.2 Oncology Drugs Product Offered
11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bristol-Myers Squibb News
11.5 Johnson & Johnson
11.5.1 Company Details
11.5.2 Oncology Drugs Product Offered
11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson News
11.6 Novartis
11.6.1 Company Details
11.6.2 Oncology Drugs Product Offered
11.6.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Novartis News
11.7 Pfizer
11.7.1 Company Details
11.7.2 Oncology Drugs Product Offered
11.7.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Pfizer News
11.8 Merck & Co.
11.8.1 Company Details
11.8.2 Oncology Drugs Product Offered
11.8.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Merck & Co. News
11.9 Amgen
11.9.1 Company Details
11.9.2 Oncology Drugs Product Offered
11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Amgen News
11.10 AstraZeneca
11.10.1 Company Details
11.10.2 Oncology Drugs Product Offered
11.10.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 AstraZeneca News
11.11 Bayer
11.12 Teva
11.13 Biogen Idec
11.14 AbbVie
11.15 Ipsen
11.16 Astellas
11.17 Eisai
11.18 Sanofi
11.19 Takeda
11.20 Otsuka
11.21 Gilead Sciences
11.22 Merck KGaA
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Oncology Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Targeted Therapy
Table 6. Major Players of Immunotherapy (Biologic Therapy)
Table 7. Major Players of Hormonal Therapy
Table 8. Major Players of Others
Table 9. Oncology Drugs Market Size by Type (2014-2019) ($ Millions)
Table 10. Global Oncology Drugs Market Size Market Share by Type (2015-2020)
Table 11. Global Oncology Drugs Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Oncology Drugs Market Size Market Share by Application (2015-2020)
Table 13. Global Oncology Drugs Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Oncology Drugs Revenue Market Share by Players (2018-2020)
Table 15. Global Oncology Drugs Key Players Head office and Products Offered
Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Oncology Drugs Market Size Market Share by Regions 2015-2020
Table 21. Americas Oncology Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Oncology Drugs Market Size Market Share by Countries (2015-2020)
Table 23. Americas Oncology Drugs Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas Oncology Drugs Market Size Market Share by Type (2015-2020)
Table 25. Americas Oncology Drugs Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Oncology Drugs Market Size Market Share by Application (2015-2020)
Table 27. APAC Oncology Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Oncology Drugs Market Size Market Share by Regions (2015-2020)
Table 29. APAC Oncology Drugs Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC Oncology Drugs Market Size Market Share by Type (2015-2020)
Table 31. APAC Oncology Drugs Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Oncology Drugs Market Size Market Share by Application (2015-2020)
Table 33. Europe Oncology Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Oncology Drugs Market Size Market Share by Countries (2015-2020)
Table 35. Europe Oncology Drugs Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe Oncology Drugs Market Size Market Share by Type (2015-2020)
Table 37. Europe Oncology Drugs Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Oncology Drugs Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Oncology Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Oncology Drugs Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Oncology Drugs Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa Oncology Drugs Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Oncology Drugs
Table 46. Key Application and Potential Industries of Oncology Drugs
Table 47. Key Challenges of Oncology Drugs
Table 48. Key Trends of Oncology Drugs
Table 49. Global Oncology Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Oncology Drugs Market Size Market Share Forecast by Regions
Table 51. Global Oncology Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global Oncology Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global Oncology Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Oncology Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 55. Roche Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 56. Roche Oncology Drugs Product Offered
Table 57. Roche Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 58. Roche Main Business
Table 59. Roche Latest Developments
Table 60. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 61. Eli Lilly Oncology Drugs Product Offered
Table 62. Eli Lilly Main Business
Table 63. Eli Lilly Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 64. Eli Lilly Latest Developments
Table 65. Celgene Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 66. Celgene Oncology Drugs Product Offered
Table 67. Celgene Main Business
Table 68. Celgene Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 69. Celgene Latest Developments
Table 70. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 71. Bristol-Myers Squibb Oncology Drugs Product Offered
Table 72. Bristol-Myers Squibb Main Business
Table 73. Bristol-Myers Squibb Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 74. Bristol-Myers Squibb Latest Developments
Table 75. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 76. Johnson & Johnson Oncology Drugs Product Offered
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 79. Johnson & Johnson Latest Developments
Table 80. Novartis Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 81. Novartis Oncology Drugs Product Offered
Table 82. Novartis Main Business
Table 83. Novartis Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 84. Novartis Latest Developments
Table 85. Pfizer Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 86. Pfizer Oncology Drugs Product Offered
Table 87. Pfizer Main Business
Table 88. Pfizer Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 89. Pfizer Latest Developments
Table 90. Merck & Co. Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 91. Merck & Co. Oncology Drugs Product Offered
Table 92. Merck & Co. Main Business
Table 93. Merck & Co. Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 94. Merck & Co. Latest Developments
Table 95. Amgen Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 96. Amgen Oncology Drugs Product Offered
Table 97. Amgen Main Business
Table 98. Amgen Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 99. Amgen Latest Developments
Table 100. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 101. AstraZeneca Oncology Drugs Product Offered
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Oncology Drugs Revenue and Gross Margin (2018-2020E)
Table 104. AstraZeneca Latest Developments
Table 105. Bayer Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 106. Teva Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 107. Biogen Idec Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 108. AbbVie Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 109. Ipsen Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 110. Astellas Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 111. Eisai Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 112. Sanofi Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 113. Takeda Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 114. Otsuka Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 115. Gilead Sciences Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
Table 116. Merck KGaA Details, Company Total Revenue (in $ million), Head Office, Oncology Drugs Major Market Areas and Its Competitors
List of Figures
Figure 1. Oncology Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Oncology Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Oncology Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Chemotherapy Market Size Growth Rate
Figure 6. Global Targeted Therapy Market Size Growth Rate
Figure 7. Global Immunotherapy (Biologic Therapy) Market Size Growth Rate
Figure 8. Global Hormonal Therapy Market Size Growth Rate
Figure 9. Global Others Market Size Growth Rate
Figure 10. Oncology Drugs in Blood Cancer
Figure 11. Global Oncology Drugs Market: Blood Cancer (2015-2020) ($ Millions)
Figure 12. Oncology Drugs in Breast Cancer
Figure 13. Global Oncology Drugs Market: Breast Cancer (2015-2020) ($ Millions)
Figure 14. Oncology Drugs in Gastrointestinal Cancer
Figure 15. Global Oncology Drugs Market: Gastrointestinal Cancer (2015-2020) ($ Millions)
Figure 16. Global Gastrointestinal Cancer YoY Growth ($ Millions)
Figure 17. Oncology Drugs in Prostate Cancer
Figure 18. Global Oncology Drugs Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 19. Global Prostate Cancer YoY Growth ($ Millions)
Figure 20. Oncology Drugs in Respiratory or Lung Cancer
Figure 21. Global Oncology Drugs Market: Respiratory or Lung Cancer (2015-2020) ($ Millions)
Figure 22. Global Respiratory or Lung Cancer YoY Growth ($ Millions)
Figure 23. Global Oncology Drugs Market Size Market Share by Application in 2019
Figure 24. Global Oncology Drugs Market Size Market Share by Regions 2015-2020
Figure 25. Americas Oncology Drugs Market Size 2015-2020 ($ Millions)
Figure 26. APAC Oncology Drugs Market Size 2015-2020 ($ Millions)
Figure 27. Europe Oncology Drugs Market Size 2015-2020 ($ Millions)
Figure 28. Middle East & Africa Oncology Drugs Market Size 2015-2020 ($ Millions)
Figure 29. Americas Oncology Drugs Market Size Market Share by Countries in 2019
Figure 30. Americas Oncology Drugs Market Size Market Share by Type in 2019
Figure 31. Americas Oncology Drugs Market Size Market Share by Application in 2019
Figure 32. United States Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 33. Canada Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 34. Mexico Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 35. APAC Oncology Drugs Market Size Market Share by Regions in 2019
Figure 36. APAC Oncology Drugs Market Size Market Share by Type in 2019
Figure 37. APAC Oncology Drugs Market Size Market Share by Application in 2019
Figure 38. China Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 39. Japan Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 40. Korea Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 41. Southeast Asia Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. India Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 43. Australia Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 44. Europe Oncology Drugs Market Size Market Share by Countries in 2019
Figure 45. Europe Oncology Drugs Market Size Market Share by Type in 2019
Figure 46. Europe Oncology Drugs Market Size Market Share by Application in 2019
Figure 47. Germany Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 48. France Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 49. UK Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 50. Italy Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. Russia Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 52. Spain Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 53. Middle East & Africa Oncology Drugs Market Size Market Share by Countries in 2019
Figure 54. Middle East & Africa Oncology Drugs Market Size Market Share by Type in 2019
Figure 55. Middle East & Africa Oncology Drugs Market Size Market Share by Application in 2019
Figure 56. Egypt Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 57. South Africa Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 58. Israel Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 59. Turkey Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 60. GCC Countries Oncology Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 61. Global Oncology Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 62. Americas Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 63. APAC Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 64. Europe Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 65. Middle East & Africa Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 66. United States Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Canada Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Mexico Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Brazil Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 70. China Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 71. Japan Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Korea Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Southeast Asia Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 74. India Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 75. Australia Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 76. Germany Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 77. France Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 78. UK Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Italy Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 80. Russia Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 81. Spain Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 82. Egypt Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 83. South Africa Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 84. Israel Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 85. Turkey Oncology Drugs Market Size 2021-2025 ($ Millions)
Figure 86. GCC Countries Oncology Drugs Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets